Characterization of Exosomes Platelets-released
NCT06298682 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 175
Last updated 2024-03-12
Summary
Extracellular vesicles (EVs) play a key role in cell-to-cell communication. They are small vesicles that contain rich molecular cargo. Recently, they have been proposed as biomarkers for clinical diagnostics. EVs include three classes: small EVs (exosomes), large EVs (microparticles), and apoptotic bodies. Platelet-derived EVs (PEVs) are the most abundant class in human blood and can actively participate in numerous physiological and pathological processes. The information about the role of platelet exosomes in cardiovascular disease and the effect of antiplatelet agents on their release and content is very limited.
Conditions
- Platelet Thrombus
Sponsors & Collaborators
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
collaborator OTHER -
Centro Cardiologico Monzino
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-07-08
- Primary Completion
- 2026-07-07
- Completion
- 2027-07-07
Countries
- Italy
Study Locations
More Related Trials
-
Role of Mesenchymal Stromal Cell Derived Extracellular Vesicles of Primary Myelofibrosis Patients on CD34+ Cells
NCT06896344 ·Status: RECRUITING
-
Monocentric Trial: Stem Cell Emergency Life Threatening Limbs Arteriopathy (SCELTA)
NCT02454231 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety of Extracellular Vesicles for Burn Wounds
NCT05078385 ·Status: COMPLETED ·Phase: PHASE1
-
Collection of Donated Placenta for Isolation of Mitochondria for Research and for Future Use in Mitochondrial Augmentation Therapies
NCT03762512 ·Status: RECRUITING
-
Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb Ischemia
NCT02993809 ·Status: UNKNOWN ·Phase: PHASE1
-
Autologous Peripheral Blood Mononuclear Cells in Diabetic Foot Patients With No-option Critical Limb Ischemia
NCT04255004 ·Status: COMPLETED ·Phase: NA
-
AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial
NCT05491681 ·Status: WITHDRAWN ·Phase: PHASE1
-
Stem Cell Injection for Peripheral Vascular Disease
NCT00278603 ·Status: COMPLETED ·Phase: PHASE1
-
Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)
NCT03423732 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia
NCT01595776 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)
NCT02805023 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Bone Marrow Progenitor Cell Mobilization in Diabetes
NCT01102699 ·Status: COMPLETED ·Phase: PHASE4
-
MSC Therapy in Liver Transplantation
NCT02260375 ·Status: RECRUITING ·Phase: PHASE1
-
Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy
NCT02368587 ·Status: UNKNOWN ·Phase: PHASE2
-
Vascular Regenerative Cell Exhaustion in Adults with Peripheral Artery Disease (PAD-VRCE)
NCT06626646 ·Status: RECRUITING
-
Expanded Access for Use of bmMSC-Derived Extracellular Vesicles in Patients With COVID-19 Associated ARDS
NCT04657458 ·Status: NO_LONGER_AVAILABLE
-
Co-transplantation of Mesenchymal Stem Cell Derived Exosomes and Autologous Mitochondria for Patients Candidate for CABG Surgery
NCT05669144 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Phase I Trial of Endocavitary Injection of Bone Marrow Derived CD133+ Cells in Ischemic Refractory Cardiomyopathy (RECARDIO Trial)
NCT02059681 ·Status: COMPLETED ·Phase: PHASE1
-
REgenerative CardiOsphere iNjection to STRengthen dysfUnCTional Hearts
NCT01496209 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Tolerance Clinical Study on Aerosol Inhalation of Mesenchymal Stem Cells Exosomes In Healthy Volunteers
NCT04313647 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress
NCT04728698 ·Status: WITHDRAWN ·Phase: PHASE2
-
Treatment of Moyamoya Disease With iPSC-derived Exosomes
NCT07065409 ·Status: RECRUITING ·Phase: PHASE1
-
Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction
NCT00555828 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Clinical Outcomes of Autologous Bone Marrow Aspirate Concentrate Injections for Musculoskeletal Conditions
NCT02981394 ·Status: WITHDRAWN
-
UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia
NCT03913026 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2